The influence of the initial clinical presentation of upper tract urothelial carcinoma on histopathological tumor features
Springer Science and Business Media LLC - Trang 1-7 - 2023
Tóm tắt
To investigate the influence of the initial clinical presentation (symptomatic vs. asymptomatic) on histopathological tumor features in patients with upper tract urothelial carcinoma (UTUC). We conducted a single-center, cross-sectional, and retrospective study that enrolled 72 adults with primary UTUC who underwent radical nephroureterectomy at our institution over a period of 4 years (April 2019–April 2023). Symptomatic patients exhibited significantly higher frequencies of high-grade UTUC (73.6% vs. 36.8%, p = 0.006), ≥ T2 stage UTUC (60.4% vs. 26.3%, p = 0.007), and larger tumor sizes (median 5 vs. 4 cm, p = 0.015) compared to asymptomatic patients. Multiple regression analyses demonstrated significant associations between symptomatic presentation and the presence of high-grade UTUC (OR 6.35, 95% CI 1.81–22.27, p = 0.004), ≥ T2 stage UTUC (OR 5.98, 95% CI 1.62–22.08, p = 0.007), and larger tumor size (B 3.14, 95% CI 0.62–5.66, p = 0.015). A subset of patients with hematuria was separately analyzed to assess the influence of hematuria severity (gross vs. microscopic) on UTUC characteristics. Patients with gross hematuria exhibited significantly higher frequencies of high-grade UTUC (72.9% vs. 33.3%, p = 0.048) and ≥ T2 stage UTUC (58.3% vs. 22.2%, p = 0.001). Multiple regression analyses showed significant associations between gross hematuria and the presence of high-grade UTUC (OR 6.34, 95% CI 1.15–34.95, p = 0.034) and ≥ T2 stage UTUC (OR 6.54, 95% CI 1.11–38.93, p = 0.039). Initial symptomatic presentation was independently associated with adverse histopathological UTUC characteristics, potentially attributed to earlier detection of UTUC in asymptomatic patients, before the onset of symptoms.
Tài liệu tham khảo
Siegel RL, Miller KD, Fuchs HE, Jemal A (2017) Cancer statistics, 2021. CA Cancer J Clin 71(1):7–33. https://doi.org/10.3322/caac.21654
Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E et al (2009) Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration. Cancer 115(6):1224–1233. https://doi.org/10.1002/cncr.24135
Abouassaly R, Alibhai SM, Shah N, Timilshina N, Fleshner N, Finelli A (2010) Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 76(4):895–901. https://doi.org/10.1016/j.urology.2010.04.020
Mbeutcha A, Rouprêt M, Kamat AM, Karakiewicz PI, Lawrentschuk N, Novara G et al (2017) Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review. World J Urol 35(3):337–353. https://doi.org/10.1007/s00345-016-1826-2
Ma R, Liu Z, Cheng Y, Zhou P, Pan Y, Bi H et al (2022) Prognostic value of tumor size in patients with upper tract urothelial carcinoma: a systematic review and meta-analysis. Eur Urol Open Sci 42:19–29. https://doi.org/10.1016/j.euros.2022.06.001
Baard J, Cormio L, Cavadas V, Alcaraz A, Shariat SF, de la Rosette J et al (2021) Contemporary patterns of presentation, diagnostics and management of upper tract urothelial cancer in 101 centres: the clinical research office of the endourological society global upper tract urothelial carcinoma registry. Curr Opin Urol 31(4):354–362. https://doi.org/10.1097/MOU.0000000000000899
Lumbreras B, Donat L, Hernández-Aguado I (2010) Incidental findings in imaging diagnostic tests: a systematic review. Br J Radiol 83(988):276–289. https://doi.org/10.1259/bjr/98067945
Kamecki H, Dębowska M, Poleszczuk J, Demkow T, Przewor A, Nyk Ł et al (2023) Incidental diagnosis of urothelial bladder cancer: associations with overall survival. Cancers (Basel) 15(3):668. https://doi.org/10.3390/cancers15030668
Jakus D, Šolić I, Jurić I, Borovac JA, Šitum M (2023) The impact of the initial clinical presentation of bladder cancer on histopathological and morphological tumor characteristics. J Clin Med 12(13):4259. https://doi.org/10.3390/jcm12134259
Raman JD, Shariat SF, Karakiewicz PI, Lotan Y, Sagalowsky AI, Roscigno M et al (2011) Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urol Oncol 29(6):716–723. https://doi.org/10.1016/j.urolonc.2009.11.007
Fang D, Gong YQ, Singla N, Yang KL, Xiong GY, Zhang L et al (2018) The significance of the initial symptom in Chinese patients with upper tract urothelial carcinoma: regular health examination is still underutilized. Kaohsiung J Med Sci 34(9):511–521. https://doi.org/10.1016/j.kjms.2018.01.003
Zeng S, Ying Y, Yu X, Wang L, Zhang Z, Xu C (2021) Impact of previous, simultaneous or intravesical recurrence bladder cancer on prognosis of upper tract urothelial carcinoma after nephroureterectomy: a large population-based study. Transl Androl Urol 10(12):4365–4375. https://doi.org/10.21037/tau-21-758
Netto GJ, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A et al (2022) The 2022 world health organization classification of tumors of the urinary system and male genital organs-part B: prostate and urinary tract tumors. Eur Urol 82(5):469–482. https://doi.org/10.1016/j.eururo.2022.07.002
Brierley JD, Gospodarowicz MK, Wittekind C (2017) TNM Classification of Malignant Tumours. 8th Edition. John Wiley & Sons, Ltd., pp 202–207.
Yeh HC, Jan HC, Wu WJ, Li CC, Li WM, Ke HL et al (2015) Concurrent preoperative presence of hydronephrosis and flank pain independently predicts worse outcome of upper tract urothelial carcinoma. PLoS ONE 10:e0139624. https://doi.org/10.1371/journal.pone.0139624
Yeh HC, Chang CH, Fang JK, Chen IA, Lin JT, Hong JH et al (2022) The value of preoperative local symptoms in prognosis of upper tract urothelial carcinoma after radical nephroureterectomy: a retrospective. Multicenter Cohort Study Front Oncol 12:872849. https://doi.org/10.3389/fonc.2022.872849
Sun KN, Wu JH, Chen ZH, He YJ, Chen YL, Hu JZ et al (2023) Predictive value of flank pain and gross hematuria on long-term survival in patients with upper tract urothelial carcinoma treated by radical nephroureterectomy. Clin Med Insights Oncol 17:11795549221147992. https://doi.org/10.1177/11795549221147993
Qi N, Zhang J, Chen Y, Wen R, Li H (2018) Microscopic hematuria predicts lower stage in patients with upper tract urothelial carcinoma. Cancer Manag Res 10:4929–4933. https://doi.org/10.2147/CMAR.S180606
Fujii Y, Sato Y, Suzuki H, Kakiuchi N, Yoshizato T, Lenis AT et al (2021) Molecular classification and diagnostics of upper urinary tract urothelial carcinoma. Cancer Cell 39(6):793-809.e8. https://doi.org/10.1016/j.ccell.2021.05.008
Warrick JI, Knowles MA, Yves A, van der Kwast T, Grignon DJ, Kristiansen G et al (2020) Report from the international society of urological pathology (ISUP) consultation conference on molecular pathology of urogenital cancers ii molecular pathology of bladder cancer: progress and challenges. Am J Surg Pathol 44(7):e30–e46. https://doi.org/10.1097/PAS.0000000000001453
Pallauf M, König F, D’Andrea D, Laukhtina E, Mostafaei H, Motlagh RS et al (2022) A systematic review and meta-analysis of prognostic nomograms after UTUC surgery. Front Oncol 12:907975. https://doi.org/10.3389/fonc.2022.907975
Seisen T, Colin P, Hupertan V, Yates DR, Xylinas E, Nison L et al (2014) Postoperative nomogram to predict cancer-specific survival after radical nephroureterectomy in patients with localised and/or locally advanced upper tract urothelial carcinoma without metastasis. BJU Int 114(5):733–740. https://doi.org/10.1111/bju.12631
Rouprêt M, Gontero P, Birtle A, Compérat EM, Dominguez-Escrig JL, Liedberg F, et al (2023) EAU Guidelines on Upper Urinary Tract Urothelial Carcinoma; EAU Guidelines Office: Arnhem, The Netherlands, ISBN 978–94–92671–19–6.